Retention Rate, Persistence and Safety of Adalimumab in Inflammatory Bowel Disease: A Real-Life, 9-Year, Single-Center Experience in Italy

被引：0
|
作者：
Alessandro Sartini
Eleonora Scaioli
Elisa Liverani
Matteo Bellanova
Luigi Ricciardiello
Franco Bazzoli
Andrea Belluzzi
机构：
[1] University of Bologna,Department of Medical and Surgical Sciences, Sant’Orsola
来源：
Digestive Diseases and Sciences | 2019年 / 64卷
关键词：
Crohn’s disease; Ulcerative colitis; Adalimumab; Persistence; Retention rate; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 874
页数：11
相关论文
共 50 条
  • [31] The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease
    Glazier, KD
    Palance, AL
    Griffel, LH
    Das, KM
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2005, 39 (01) : 21 - 26
  • [32] Infliximab safety profile and long-term applicability in inflammatory bowel disease: 9-year experience in clinical practice
    Zabana, Y.
    Domenech, E.
    Manosa, M.
    Garcia-Planella, E.
    Bernal, I.
    Cabre, E.
    Gassull, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 31 (05) : 553 - 560
  • [33] CLINICAL RESPONSE, EFFECTIVENESS, SAFETY AND MUCOSAL HEALING INDUCTION OF VEDOLIZUMAB IN INFLAMMATORY BOWEL DISEASE: A PRELIMINARY REAL-LIFE MULTICENTRIC EXPERIENCE IN SOUTHERN ITALY
    Contaldo, A.
    Losurdo, G.
    Bossa, F.
    Biscaglia, G.
    Mazzuoli, S.
    Fanigliulo, L.
    Tursi, A.
    Lovero, R.
    Ierardi, E.
    Principi, M. B.
    Di Leo, A.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E198 - E198
  • [34] Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience
    Pouillon, Lieven
    Baumann, Cedric
    Rousseau, Helene
    Choukour, Myriam
    Andrianjafy, Charlotte
    Danese, Silvio
    Peyrin-Biroulet, Laurent
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (05) : 945 - 954
  • [35] Efficacy and Safety of Omalizumab in Severe Allergic Asthma and Allergic Comorbidities: A Single-Center, Real-Life Experience in China
    Zhao, L.
    Zou, C.
    Zhu, Y.
    Wu, X.
    Wang, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [36] EFFICACY AND SAFETY OF INFLIXIMAB AND ADALIMUMAB IN CROHN'S DISEASE PATIENTS IN A SINGLE IBD CENTER: A RETROSPECTIVE REAL-LIFE STUDY
    Desideri, F.
    Pagnini, C.
    Menasci, F.
    Capasso, M.
    Corleto, V. D.
    Delle Fave, G.
    DIGESTIVE AND LIVER DISEASE, 2016, 48 : E199 - E200
  • [37] Safety and efficacy of transitioning inflammatory bowel disease patients from intravenous to subcutaneous infliximab: a single-center real-world experience
    Jeffrey, Angus W.
    Abu-Rgeef, Reeham
    Picardo, Sherman
    Menon, Shankar
    So, Kenji
    Venugopal, Kannan
    ANNALS OF GASTROENTEROLOGY, 2023, : 549 - 554
  • [38] Real-life outcomes of unselected acute promyelocytic leukemia patients: a single-center 14-year experience
    Akcay, Omer Faruk
    Yeter, Haci Hasan
    Buyukasik, Yahya
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2020, 58 (03) : 138 - 145
  • [39] Long-term efficacy and safety of ustekinumab for moderate-to-severe psoriasis: A 9-year real-life experience from a tertiary referral center in Turkey
    Kobaner, Goncagul Babuna
    Ekinci, Algun Polat
    Kutlay, Armagan
    DERMATOLOGIC THERAPY, 2021, 34 (04)
  • [40] Gastric Diffuse Large B-Cell Lymphoma: A Single-Center 9-Year Experience
    Couto, Maria Eduarda
    Oliveira, Isabel
    Domingues, Nelson
    Viterbo, Luisa
    Martins, Angelo
    Moreira, Ilidia
    Espirito-Santo, Ana
    Chacim, Sergio
    Moreira, Claudia
    Pereira, Dulcineia
    Henrique, Rui
    Mariz, Jose
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2021, 37 (03) : 492 - 496
12345